Abbott wins FDA nod for Epic Max stented tissue valve
Abbott (NYSE:ABT) announced today that the FDA approved its Epic Max stented tissue valve for treating aortic regurgitation or stenosis.
Source: massdevice.com
Stay updated with breaking news from Epic Plus Supra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott (NYSE:ABT) announced today that the FDA approved its Epic Max stented tissue valve for treating aortic regurgitation or stenosis.
Abbott (NYSE:ABT) announced today that the FDA approved its Epic Max stented tissue valve for treating aortic regurgitation or stenosis.